Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors

Journal of Thoracic Oncology

Volumn 5, Issue 12, 2010, Pages 1994-1998

  Jatoi, Aminah ^a   Soori, Gamini ^b   Foster, Nathan R ^a   Hiatt, Bradley K ^c   Knost, James A ^d   Fitch, Tom R ^e   Callister, Matthew D ^e   Nichols III, Francis C ^a   Husted, Tim M ^f   Alberts, Steven R ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b MISSOURI VALLEY CANCER CONSORTIUM   (United States)

^c Iowa Oncology Research Association CCOP   (United States)

^d Illinois Oncology Research Association CCOP   (United States)

^e MAYO CLINIC   (United States)

^f Toledo Community Hospital Oncology Program CCOP   (United States)

Author keywords

Carboplatin; Esophageal Cancer; Pemetrexed; Radiation; Surgery

Indexed keywords

CARBOPLATIN; CYANOCOBALAMIN; DEXAMETHASONE; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PEMETREXED;

ADJUVANT THERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM CANCER; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; ESOPHAGUS CANCER; ESOPHAGUS PAIN; ESOPHAGUS SURGERY; FEMALE; GASTROESOPHAGEAL JUNCTION CANCER; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOXIA; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; NAUSEA; NECK PAIN; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SCORING SYSTEM; SMALL INTESTINE OBSTRUCTION; SOFT TISSUE INFECTION; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

EID: 78650509692     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181fb5c3e     Document Type: Article

References (17)

1. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467. (Pubitemid 26269945)
2. Jin HL, Zhu H, Ling TS, et al. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol 2009;15:5983-5991.
3. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925-930. (Pubitemid 38824146)
4. Greer SE, Goodney PP, Sutton JE, et al. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005;137:172-177. (Pubitemid 40174424)
5. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;25:1160-1168. (Pubitemid 46291702)
6. Meluch AA, Greco FA, Gray JR, et al. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J 2003;9:251-260.
7. Seiwert TY, Connell PP, Mauer AM, et al. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res 2007;13:515-522. (Pubitemid 46225357)
8. Bajetta E, Celio L, Buzzoni R, et al. Phase II study of pemetrexed disodium administered with oral folic acid in patients with advanced gastric cancer. Ann Oncol 2003;14:1543-1548. (Pubitemid 37304611)
9. Celio L, Buzzoni R, Longarini R, et al. Pemetrexed in gastric cancer: clinical experience and future perspectives. Semin Oncol 2002; 29(Suppl 18):63-68. (Pubitemid 36176678)
10. Ruhstaller T, Widmer L, Schuller JC, et al. Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal cancer (SAKK 75/02). Ann Oncol 2009;20:1522-1528.
11. Stahl M, Walz MK, Stiuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851-856.
12. Rivera F, Galan M, Tabernero J, et al. Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. Int J Radiat Oncol Biol Phys 2009;75:1430-1436.
13. Ajani JA, Correa AM, Walsh GL, et al. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 2010; 116:1656-1663.
14. Chiarion-Sileni V, Innocente R, Cavina R, et al. Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin, and oxaliplatin in locally advanced esophageal cancer. Cancer Chemother Pharmacol 2009;63:1111-1119.
15. Kim D, Blanke CD, Wu H, et al. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 2007;67:397-404. (Pubitemid 46108316)
16. Henry LR, Goldberg M, Scott W, et al. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report. Ann Surg Oncol 2006;13:214-220. (Pubitemid 43157416)
17. Keresztes RS, Port JL, Pasmantier MW, et al. Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial. J Thorac Cardiovasc Surg 2003;126:1603-1608. (Pubitemid 37449194)